The company entered a $2 billion accelerated share repurchase (ASR) agreement, indicating significant financial health and available capital. This focus on capital allocation and shareholder value suggests the company is in a strong budgetary position for strategic investments.
Filing excerpt
On May 18, 2026, Boston Scientific Corporation (the “Company”) issued a press release announcing that the Company has entered into an accelerated share repurchase (“ASR”) agreement with JPMorgan Chase Bank, National Association for $2 billion (the “Repurchase Price”) of its common stock, as part of its previously announced $5 billion share repurchase authorization.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
Vendors named
sec-8kmaterialContractGet every 8-K signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/dcf88bcc-b4d1-4813-8ef7-0164cf2b0592 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "dcf88bcc-b4d1-4813-8ef7-0164cf2b0592",
"signal_type": "sec-8k",
"signal_subtype": "materialContract",
"detected_at": "2026-05-19T10:14:18.625+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "The company entered a $2 billion accelerated share repurchase (ASR) agreement, indicating significant financial health and available capital. This focus on capital allocation and shareholder value suggests the company is in a strong budgetary position for strategic investments.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Accelerated share repurchase agreement price",
"dollar_millions": 2000
},
"summary": "Boston Scientific launches $2B accelerated share repurchase program, signaling strong cash position.",
"excerpts": "On May 18, 2026, Boston Scientific Corporation (the “Company”) issued a press release announcing that the Company has entered into an accelerated share repurchase (“ASR”) agreement with JPMorgan Chase Bank, National Association for $2 billion (the “Repurchase Price”) of its common stock, as part of its previously announced $5 billion share repurchase authorization.",
"relevance": 0.75,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000042/bsx-20260518.htm",
"filing_date": "2026-05-18",
"filing_year": 2026,
"fiscal_year_end": "05/18",
"sales_relevance": "Vendor relationship signal",
"signal_category": "strategic",
"vendors_mentioned": [
"JPMorgan Chase Bank, National Association"
]
}
}
curl https://signals.autobound.ai/v1/signals/dcf88bcc-b4d1-4813-8ef7-0164cf2b0592 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.